Literature DB >> 26547366

Aberrant metastatic behavior and particular features of early gastric cancer.

Simona Gurzu1, Ioan Jung1, Zoltan Kadar1,2.   

Abstract

In this paper, we have focused on the metastatic behavior of EGC and its particularities. The main factors that are currently considered as predictors of the metastatic behavior and that are used in the therapeutic decision (endoscopic resection vs surgical removal) are the tumor size (upper or bellow 2 cm), depth of infiltration, angiolymphatic invasion, the presence or absence of ulceration, and histologic type (undifferentiated vs differentiated carcinomas). However, most of the metastatic cases were published as case reports or case series. This is the reason why a proper estimation of metastatic risk in EGC is not well known. To date, 79 cases presenting bone metastases, three reports of brain metastases, and one EGC that was associated with skin metastasis were published. However, occult metastasis, lymph node micrometastasis, and skip metastasis can also occur and should be identified. Making a synthesis of the literature data that is correlated with our experience, we finally proposed the inclusion of the six Japanese subgrouping system, tumor size, angiolymphatic invasion, and micrometastasis as components of the pTNM staging system, which should be particularly adapted for EGC.
© 2015 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Skip metastases; brain; micrometastases; skin; stump

Mesh:

Year:  2015        PMID: 26547366     DOI: 10.1111/apm.12469

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Immunohistochemical features and staging of early gastric cancer.

Authors:  Simona Gurzu; Janina Orlowska; Haruhiko Sugimura; Tivadar Bara; Zoltan Szentirmay; Wladyslaw Januszewicz; Tivadar Bara; Janos Szederjesi; Ioan Jung
Journal:  Arch Med Sci       Date:  2016-03-22       Impact factor: 3.318

Review 2.  Value and impact factors of multidetector computed tomography in diagnosis of preoperative lymph node metastasis in gastric cancer: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Mingxu Luo; You Lv; Xiuyu Guo; Hongmei Song; Guoqiang Su; Bo Chen
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

3.  A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer.

Authors:  Liang Ma; Jian Gong; Meimei Zhao; Xiaomu Kong; Peng Gao; Yongwei Jiang; Yi Liu; Xiaoyan Feng; Shuang Si; Yongtong Cao
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

4.  Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.

Authors:  Jiuda Zhao; Feng Du; Yu Zhang; Jie Kan; Li Dong; Guoshuang Shen; Fangchao Zheng; Hui Chen; Junhui Zhao; Faxiang Ji; Yang Luo; Fei Ma; Ziyi Wang; Binghe Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 5.  Current status of lymph node micrometastasis in gastric cancer.

Authors:  Yang Zhou; Guo-Jing Zhang; Ji Wang; Kai-Yuan Zheng; Weihua Fu
Journal:  Oncotarget       Date:  2017-04-27

6.  Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET.

Authors:  Joon-Kee Yoon; Cheulsu Byun; Kyung Sook Jo; Hun Hur; Kee Myung Lee; Seon Kyo Lim; Dakeun Lee; Su Jin Lee; Young-Sil An; Sang-Uk Han
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Small early gastric cancer with synchronous bone metastasis: A case report.

Authors:  Isao Fujita; Tatsuya Toyokawa; Takafumi Makino; Katsunori Matsueda; Shizuma Omote; Joichiro Horii
Journal:  Mol Clin Oncol       Date:  2020-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.